EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Therapeutic Antibodies for Infectious Diseases: Recent Past, Present, and Future

Sriram Subramaniam iD, James W Saville, Frank Feng, Lee Freiburger

Biochemistry · 2025

DOI: 10.1021/acs.biochem.5c00192 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemistry, 2025. Verfasst von Sriram Subramaniam und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC V6T 1Z3, Canada. Hauptthemen laut MEDLINE: COVID-19 Drug Treatment, Antibodies, Viral, Antibodies, Monoclonal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canada Excellence Research Chairs, Government of Canada, Canada Biomedical Research Fund, VGH Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A central goal of modern infectious disease research is to discover safe prophylactic vaccines that can prevent infection. When this is not possible, or when preventive vaccines are still in development, it is critical to have interventions that can mitigate the spread of the disease both within infected individuals and in the population. In this short review, we explore the recent history of therapeutic antibody use, highlighting antibodies used over the last five years to treat COVID-19. We outline some of the challenges in developing antibodies rapidly in response to pandemic threats and suggest that emerging technologies for AI-driven design may offer exciting opportunities for the development of a broad class of protein therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 Drug TreatmentAntibodies, ViralAntibodies, MonoclonalHumansSARS-CoV-2COVID-19Antibodies, NeutralizingAnimals

Substanzen

Antibodies, ViralAntibodies, MonoclonalAntibodies, Neutralizing

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • Gandeeva Therapeutics, Inc, Burnaby, BC V5C 6N5, Canada.
  • Meso Scale Diagnostics LLC, Rockville, Maryland 20850, United States.

ORCID-Profile: Sriram Subramaniam

Förderung

  • Canada Excellence Research Chairs, Government of Canada
  • Canada Biomedical Research Fund
  • VGH Foundation

Zitieren

APA

Subramaniam, S., Saville, J. W., Feng, F., & Freiburger, L. (2025). Therapeutic Antibodies for Infectious Diseases: Recent Past, Present, and Future. Biochemistry. https://doi.org/10.1021/acs.biochem.5c00192

Vancouver

Subramaniam S, Saville JW, Feng F, Freiburger L. Therapeutic Antibodies for Infectious Diseases: Recent Past, Present, and Future. Biochemistry. 2025. doi:10.1021/acs.biochem.5c00192

BibTeX
@article{Subramaniam2025,
  author = {Subramaniam, Sriram and Saville, James W and Feng, Frank and Freiburger, Lee},
  title = {Therapeutic Antibodies for Infectious Diseases: Recent Past, Present, and Future},
  journal = {Biochemistry},
  year = {2025},
  doi = {10.1021/acs.biochem.5c00192}
}
Kostenlos starten →